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Conclusion: Prompt recognition of
extrahepatic collaterals of HCC plays a key
     
most common collateral supply is from the
inferior phrenic artery. Several imaging
clues often suggest potential development of
parasitic blood supply, and in such cases we
recommend IPA angiography be preformed
during TACE procedures. Prophylactic
embolization of non-tumor feeding IPA
branches is important in avoiding non-target
embolization. 
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following RF depletion, and discriminative
ability between RA and OA.

detection analytes. Thus, we evaluated the
performance of a commercially available
multiplex platform and assessed the impact of
RF depletion.

Mentor: Ted Mikuls
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Type: Original Research

Results: Of the 44 cytokines analyzed in
duplicate, 22 yielded CVs <10%; only 3
demonstrated CVs >30%. ICCs universally
exceeded 0.85 with the exception of seven
analytes. RF depletion altered cytokine
values by <15% for 28 analytes with larger
changes (>30%) seen for nine analytes. Of
the 45 analytes tested, 24 differed based on
measurement in plasma vs. serum. Analytes
were frequently greater in RA vs. OA, but

Methods:     !  
using the Meso Scale Discovery V-PLEXTM
immunoassays and serum from 40 RA and 40
osteoarthritis (OA) patients. Select samples
were depleted of RF using a commercial
binder. Performance was assessed using intra     "#$%   
    "&$%     

Background: Cytokines and chemokines
(cytokines) are central to RA pathogenesis,
a fact underscored by the emergence of
multiplex immunoassays for quantifying
cytokine values. Intrinsic factors to
rheumatoid arthritis (RA), namely
rheumatoid factor (RF), may interfere with
      






 




 

 

=


6#
6'

6"

'"
6!

'#

<



  

 

'"



'







<

;



!

'





'



!69









!-











+





)+

 





 '(





#


"


!









  




 







 $%&








 

 









 





  



'%(>%?$@%



!F-%

Figure 1. Mean absolute percent change in analyte concentration following RF depletion.
* Wilcoxon signed-rank test p-value < 0.05
** Wilcoxon signed-rank test p-value < 0.01
Of the 45 analytes, 28 exhibited <15% change, eight showed intermediate changes (15-30%), and nine demonstrated >30% change. RED lines indicate cut
off points.
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greater in OA vs. RA.
Conclusion: Although this commercially
available multiplex assay generally performed
well in the context of RA, interference
induced by RF meaningfully impacted
U       
examined. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.066
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Background: A 42-year-old male presented
to sports clinic with bilateral anterolateral
lower leg pain for 1.5 years. Pain is
exacerbated by running with associated
painful swelling and “small bulges” along
the anterolateral legs. Symptoms arise
within 8 minutes of activity and cease within
5-10 minutes of rest. Physical therapy was
unsuccessful.
Methods:
• Bilateral Lower Extremity Exam:
» Inspection: Normal
» Palpation: Normal
» ROM: Normal
» Special Tests: Resisted ROM testing and
tuning fork exam normal
• Bilateral LE X-ray and MRI: normal
» Compartment Pressure Testing: See
Table 1
» Elevated post-exercise compartment
pressures noted
» With exercise, 2 cm tender bulge present
on lateral lower legs bilaterally

sparks the question if compartment testing
and botulinum toxin treatment should be
considered for all fascial hernias, including
those without CECS symptoms. With physical
therapy and gait retraining, this offers an
alternate approach to fasciotomy. 

Results:   Z     ! 
bilateral chronic exertional compartment
syndrome (CECS) with associated fascial
hernias. After counseled on treatment options
including gait retraining, botulinum toxin
injections, and fasciotomy, he received 50
units botulinum toxin at each legs’ anterior
and lateral compartments. Within 3 weeks
he reported 70% improvement and later
completed gait retraining without pain.

https://doi.org/10.32873/unmc.dc.gmerj.2.1.067

Conclusion: Lower extremity fascial hernias
may present with or without CECS symptoms.
CECS is reversible, exercise induced
ischemia at a predictable level of exercise due
to noncompliant osseofascial compartments.
Numerous cases support botulinum toxin
injections for CECS, but little evidence
exists for its use in fascial hernias. This

Table 1.
Compartment testing before and after exercise (in mm Hg).
Pre-Exercise
Left Leg

Post-Exercise
Left Leg

Pre-Exercise
Right Leg

Post-Exercise
Right Leg

Anterior

11

81

12

30

Lateral

18

35

17

22

Deep Posterior

7

26

6

7

_`q{|}~ {||

13

19

10

20
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Background: Sjögren-Larsson syndrome
(SLS) is a rare autosomal recessive
neurocutaneous disorder caused by a
mutation in the gene encoding fatty aldehyde
dehydrogenase. SLS is characterized by
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eneralized ichthyosis, seizures, cognitive
disability, spasticity, and ophthalmologic
changes. Limited resources are available to
guide anesthetic management for patients
with SLS. This case series seeks to identify
anesthetic considerations in patients with SLS.
Methods: After IRB approval, a chart
review of anesthetic records of SLS
patients from February 2013 to October
2019 was conducted. Data included age,
gender, relevant comorbid conditions

(Table 1), induction and maintenance
agents, intravenous and oral analgesics,
muscle relaxants, procedure performed, and
complications.
Results: A total of 14 patients undergoing
[\      !   
included brain MRI, botulinum toxin injection,
tendon release, and dental restoration. General
anesthesia was performed for nearly all
procedures. The most common observations
!      %    
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